Improving communication between organizations as a patient advocate
Felice Bombaci from the AIL patient group for chronic myeloid leukemia (CML), Rome, Italy, works with AIL, a patient advocacy organization, as well as a variety of patient groups and associations to improve patient disease understanding and support across a variety of blood diseases. In this video, recorded at the 1st European Myeloma Network (EMN) Meeting 2018, held in Turin, Italy, he emphasizes the importance of networking as a patient advocate. He discusses how collaboration between patients, physicians, pharmaceutical corporations, scientific organizations, and policy makers, is essential for improving treatment and support options for patients with any disease.
Get great new content delivered to your inboxSign up